REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
↓ Download CSVKey ratios (FY2025)
-229.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$20.20M | -$30.80M | -$39.50M | -$28.23M | -$10.10M | -$2.43M | -$376.9K | — |
| Net Income | -$19.86M | -$29.92M | -$39.26M | -$28.26M | -$8.52M | -$3.78M | -$846.8K | — |
| EPS (Diluted) | $-5.48 | $-17.73 | $-1.65 | $-1.45 | $-0.58 | — | — | — |
| Total Assets | $15.92M | $15.50M | $23.70M | $18.92M | $31.40M | $8.76M | $2.6K | — |
| Total Liabilities | $7.28M | $14.69M | $17.98M | $10.53M | $2.72M | $3.30M | $6.81M | — |
| Shareholders' Equity | $8.65M | $812.6K | $5.72M | $8.39M | $28.69M | $5.47M | -$6.81M | -$5.96M |
| Cash & Equivalents | $14.44M | $13.48M | $23.37M | $18.52M | $29.69M | $8.76M | $193 | $0 |
| Operating Cash Flow | -$24.59M | -$33.54M | -$28.32M | -$18.96M | -$10.67M | -$4.07M | -$218.4K | — |
| Shares Outstanding | 5.87M | 2.36M | 27.92M | 20.45M | 14.43M | 9.23M | 2.60M | — |